High-throughput bacterial profiling via MALDI spot analysis: Precise characterization of antibiotic-induced metabolic responses

Posters | 2026 | Bruker | ASMSInstrumentation
LC/MS, MALDI, Ion Mobility
Industries
Metabolomics
Manufacturer
Bruker

Significance of the topic


Spot-based MALDI mass spectrometry coupled with trapped ion mobility separation (TIMS) offers a fast, low-preparation route to metabolic fingerprinting of microbial cultures. This approach addresses the growing need for high-throughput, reproducible metabolomics workflows that can screen large sample cohorts (drug screens, phenotype profiling, antibiotic response studies) with short per-sample acquisition times and straightforward automation. Integrating TIMS improves spectral clarity and peak capacity versus conventional MALDI, enabling confident detection of small-molecule changes induced by perturbations such as antibiotics.

Objectives and overview of the study


  • Develop and demonstrate a streamlined MALDI-TIMS spot workflow for high-throughput bacterial metabolomics on the timsTOF fleX platform.
  • Showcase software-supported feature extraction and background removal using MetaboScape 2026 to enhance specificity of detected features.
  • Apply the workflow to profile metabolic responses of Escherichia coli exposed to three antibiotics (chloramphenicol, penicillin G, trimethoprim) across concentration gradients and evaluate reproducibility and specificity.

Methods and experimental workflow


  • Biological model: E. coli cultures grown in Mueller-Hinton medium; four biological replicates per condition; treatments included chloramphenicol (CLO), penicillin G (PENG), and trimethoprim (TMP) at multiple concentrations referenced to MIC.
  • Sample preparation: Cultures were extracted in 96-well format and diluted 1:10 prior to MALDI spotting. Dried-droplet spotting onto an AnchorChip MALDI target (800 μm) was performed using α-cyano-4-hydroxycinnamic acid (HCCA) matrix prepared in 85% acetonitrile, 0.1% TFA with 1 mM ammonium phosphate to promote ionization and crystal homogeneity.
  • MALDI-TIMS-MS acquisition: Measurements were acquired in positive Full-MS mode on a timsTOF fleX with TIMS-enabled ion mobility separation. Automated laser acquisition ran at 10 kHz, and the workflow achieved acquisition times under 10 seconds per spot, permitting rapid profiling of 96 samples.
  • Data processing: Raw spectra were processed in MetaboScape 2026 using the dedicated MALDI spot workflow. Blank cultivation medium spectra served as background references; features present in the medium were removed to reduce false positives. Low-intensity features (intensity ≤10) were excluded from statistical analyses. Feature extraction, mobilogram alignment and statistical visualization (PCA, series plots) were handled within MetaboScape.

Instrumentation used


  • timsTOF fleX mass spectrometer (Bruker) with Trapped Ion Mobility Spectrometry (TIMS)
  • AnchorChip MALDI target plate (800 μm spots)
  • Laser source capable of 10 kHz acquisition (integrated in timsTOF fleX)
  • MALDI matrix: α-cyano-4-hydroxycinnamic acid (HCCA) in 85% ACN, 0.1% TFA, 1 mM ammonium phosphate
  • Data analysis software: MetaboScape 2026 with MALDI spot workflow

Main results and discussion


  • Throughput and reproducibility: The workflow yielded reproducible mobilogram and spectral patterns across biological replicates, demonstrating high run-to-run consistency. Reported acquisition times were <10 seconds per spot, enabling high-throughput analysis of 96 samples in short total time.
  • Improved spectral quality via TIMS: Incorporation of TIMS separation increased peak capacity and improved signal discrimination in complex spot spectra, aiding feature detection and downstream statistical confidence.
  • Background removal effectiveness: Using blank cultivation medium spectra as an automated background reference in MetaboScape reduced matrix- and medium-derived features, increasing specificity for cellular metabolic signals and facilitating detection of treatment-related changes.
  • Antibiotic-specific metabolic responses: Multivariate analysis (PCA) separated samples treated with chloramphenicol and penicillin G into distinct clusters versus controls, indicating pronounced and treatment-specific metabolic perturbations. Trimethoprim-treated samples clustered near controls, consistent with a weaker metabolic impact in this dataset—reflecting known resistance profiles of the tested E. coli strain.
  • Concentration dependence: Series plots of selected features across antibiotic concentration gradients confirmed dose-dependent trends for treatment-specific biomarkers, supporting the method's quantitative sensitivity for comparative profiling.

Benefits and practical applications


  • High-throughput screening: Sub-10-second per-spot acquisition makes the workflow suitable for screening large panels of conditions (antibiotic libraries, phenotypic screens, time-course experiments).
  • Minimal sample preparation: Dried-droplet spotting with standard HCCA matrix and simple dilution keeps sample handling straightforward and automatable.
  • Enhanced feature confidence: TIMS separation and software-driven background subtraction reduce ambiguity from coeluting species and medium-derived signals, facilitating more reliable biomarker discovery.
  • Integration with downstream analysis: Detected statistically significant features can guide targeted MS/MS or orthogonal LC-MS workflows for structural elucidation and validation.

Future trends and applications


  • Deeper annotation pipelines: Coupling MALDI-TIMS spot profiling with rapid on-spot or follow-up MS/MS acquisition and databases will accelerate structural identification of discriminatory metabolites.
  • Automation and scale-up: Higher-density MALDI targets and robotic spotting could further increase throughput for large-scale screening campaigns and clinical research cohorts.
  • Integration into multi-omics: Combining MALDI-TIMS metabolite fingerprints with genomics, proteomics or phenotypic readouts will strengthen interpretation of antibiotic mechanisms and resistance phenotypes.
  • Quantitative advances: Standardization strategies (internal standards, calibration protocols) could improve the quantitative comparability of spot-based metabolomics across labs and instruments.

Conclusion


The study demonstrates a practical, rapid MALDI-TIMS spot workflow for bacterial metabolomic fingerprinting that achieves high throughput, reproducibility, and specificity when coupled with MetaboScape 2026 processing. TIMS-enhanced separation and software-guided background removal enable confident detection of antibiotic-specific metabolic responses and concentration-dependent trends. The approach is well suited to large-scale screening and discovery workflows, with clear pathways to integrate structural identification and multi-omics for deeper biological insight. Note: authors disclosed employment by the instrument vendor; results are reported for research use only and not for diagnostic purposes.

Reference


  • Rudt E., Asperger A., Weinkouff S., Kessler N., Mai P.Y., Thépenier C., Aros S., Gomperts Boneca I., Neuweger H., Lewis M.R. High-throughput bacterial profiling via MALDI spot analysis: Precise characterization of antibiotic-induced metabolic responses. Bruker Technical Note / Application; 2026. (Includes Technical Note 62 for additional technical details.)

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Bruker timsTOF fleX - MALDI Guided SpatialOMx
Confident 4D Annotation of Polar Metabolites Using Standardized Retention Times Combined with TIMS-HRMS Acquisition
Bruker Product Overview - Life Science Mass Spectrometry
Bruker Product Overview - Life Science Mass Spectrometry
2020|Bruker|Brochures and specifications
Bruker MRMS Applications Handbook